Consistent with our hypothesis, we postulate that the reduced immunogenicity of the Omicron variant leads to a significantly milder initial immune response [22] and in turn, milder induction of RGS2 expression and thus reduced risk of anosmia. Here, RGS2 is linked to Anosmia.